Literature DB >> 6413409

Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.

F Ameglio, M R Capobianchi, A Dolei, R Tosi.   

Abstract

Interferon-gamma affected the expression of the products of the immunoassociated antigen complex by a differential modulation of DR- and DC-locus-controlled molecules. In melanoma M14 cells treated with interferon-gamma, levels of DR molecules were increased two- to threefold, whereas levels of DC molecules were increased six- to sevenfold. Similar effects were induced on the two allelic products of each locus.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6413409      PMCID： PMC264532          DOI： 10.1128/iai.42.1.122-125.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

1.  Purification and separation of subsets of human Ia molecules by papain digestion.

Authors:  N Tanigaki; R Tosi; K Koyama; D Pressman
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

2.  Interactions of interferon with in vitro model systems involved in hematopoietic cell differentiation.

Authors:  G B Rossi; A Dolei; M R Capobianchi; C Peschle; E Affabris
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

3.  Effect of type I and type II interferons on murine thymocyte surface antigen expression: induction or selection?

Authors:  G Sonnenfeld; D Meruelo; H O McDevitt; T C Merigan
Journal:  Cell Immunol       Date:  1981-01-15       Impact factor: 4.868

4.  Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.

Authors:  J E Blalock; J A Georgiades; M P Langford; H M Johnson
Journal:  Cell Immunol       Date:  1980-02       Impact factor: 4.868

5.  HLA-DR typing by radioimmunoassay.

Authors:  R Tosi; N Tanigaki; D Centis; P L Rossi; G Alfano; G B Ferrara; D Pressman
Journal:  Transplantation       Date:  1980-04       Impact factor: 4.939

6.  Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells.

Authors:  M Fellous; M Kamoun; I Gresser; R Bono
Journal:  Eur J Immunol       Date:  1979-06       Impact factor: 5.532

7.  Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.

Authors:  B Y Rubin; S L Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

8.  The preparation of antibodies directed against human immune interferon.

Authors:  M De Ley; J Van Damme; A Billiau; P De Somer
Journal:  J Virol Methods       Date:  1981-10       Impact factor: 2.014

9.  Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon.

Authors:  I Heron; M Hokland; K Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

10.  Immunological dissection of human Ia molecules.

Authors:  R Tosi; N Tanigaki; D Centis; G B Ferrara; D Pressman
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307
View more
  4 in total

1.  Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.

Authors:  K M Haan; W W Kwok; R Longnecker; P Speck
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Biological basis for the clinical use of interferon.

Authors:  F Dianzani
Journal:  Gut       Date:  1993       Impact factor: 23.059

3.  Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma.

Authors:  W Heagy; V E Kelley; T B Strom; K Mayer; H M Shapiro; R Mandel; R Finberg
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

4.  Cytokines in cancer immunotherapy.

Authors:  Sylvia Lee; Kim Margolin
Journal:  Cancers (Basel)       Date:  2011-10-13       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.